Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

INTRODUCTION: In the PINETREE study, early remdesivir treatment reduced risk of coronavirus disease 2019 (COVID-19)-related hospitalizations or all-cause death versus placebo by 87% by day 28 in high-risk, non-hospitalized patients. Here we report results of assessment of heterogeneity of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Samuel M., Katz, Morgan J., Ginde, Adit A., Juneja, Kavita, Ramchandani, Monica, Schiffer, Joshua T., Vaca, Carlos, Gottlieb, Robert L., Tian, Yuan, Elboudwarej, Emon, Hill, Joshua A., Gilson, Richard, Rodriguez, Lauren, Hedskog, Charlotte, Chen, Shuguang, Montezuma-Rusca, Jairo M., Osinusi, Anu, Paredes, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113728/
https://www.ncbi.nlm.nih.gov/pubmed/37074613
http://dx.doi.org/10.1007/s40121-023-00789-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113728/
https://www.ncbi.nlm.nih.gov/pubmed/37074613
http://dx.doi.org/10.1007/s40121-023-00789-y

Ejemplares similares